HBV MUTATIONS ASSOCIATED WITH REDUCED SUSCEPTIBILITY TO ADEFOVIR

Details for Australian Patent Application No. 2003279103 (hide)

Owner GILEAD SCIENCES, INC.

Inventors Xiong, Xiaofeng; Delaney, William E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003279103

PCT Number PCT/US03/31243

PCT Pub. Number WO2004/031224

Priority 60/415,018 01.10.02 US

Filing date 1 October 2003

Wipo publication date 23 April 2004

International Classifications

C07K 014/02 Peptides having more than 20 amino acids

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/415,018 01.10.02 US

27 May 2004 Application Open to Public Inspection

  Published as AU-A-2003279103

18 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003279104-Single use syringe having a safety shield

2003279102-PHARMACEUTICAL COMPOSITION CONTAINING STABILISED AMORPHOUS FORM OF DONEPEZIL HYDROCHLORIDE